Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF.
This report contains market size and forecasts of Atrial Fibrillation Devices in global, including the following market information:
Global Atrial Fibrillation Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atrial Fibrillation Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Atrial Fibrillation Devices companies in 2021 (%)
The global Atrial Fibrillation Devices market was valued at 2986 million in 2021 and is projected to reach US$ 5926.3 million by 2028, at a CAGR of 10.3% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Catheter Ablation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atrial Fibrillation Devices include Abbott, Boston Scientific, Biosense Webster, Medtronic, Japan Lifeline, AtriCure, Biotronik, Philips and Synaptic Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atrial Fibrillation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atrial Fibrillation Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atrial Fibrillation Devices Market Segment Percentages, by Type, 2021 (%)
Catheter Ablation
Maze Surgery
Global Atrial Fibrillation Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atrial Fibrillation Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Atrial Fibrillation Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atrial Fibrillation Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atrial Fibrillation Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atrial Fibrillation Devices revenues share in global market, 2021 (%)
Key companies Atrial Fibrillation Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Atrial Fibrillation Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Boston Scientific
Biosense Webster
Medtronic
Japan Lifeline
AtriCure
Biotronik
Philips
Synaptic Medical
Osypka AG
MicroPort Scientific
CardioFocus
Lepu Medical
APT Med
TZ Medical
Johnson & Johnson